Abstract
Understanding binding properties at protein-protein interfaces has been limited to structural and mutational analyses of natural binding partners or small peptides identified by phage display. Here, we present a high-resolution analysis of a nonpeptidyl small molecule, previously discovered by medicinal chemistry [Tilley, J. W., et al. (1997) J. Am. Chem. Soc. 119, 7589-7590], which binds to the cytokine IL-2. The small molecule binds to the same site that binds the IL-2 alpha receptor and buries into a groove not seen in the free structure of IL-2. Comparison of the bound and several free structures shows this site to be composed of two subsites: one is rigid, and the other is highly adaptive. Thermodynamic data suggest the energy barriers between these conformations are low. The subsites were dissected by using a site-directed screening method called tethering, in which small fragments were captured by disulfide interchange with cysteines introduced into IL-2 around these subsites. X-ray structures with the tethered fragments show that the subsite-binding interactions are similar to those observed with the original small molecule. Moreover, the adaptive subsite tethered many more compounds than did the rigid one. Thus, the adaptive nature of a protein-protein interface provides sites for small molecules to bind and underscores the challenge of applying structure-based design strategies that cannot accurately predict a dynamic protein surface.
MeSH Terms
Cloning, Molecular
Crystallography, X-Ray
Humans
Interleukin-2/genetics,metabolism
Ligands
Models, Molecular
Protein Binding
Receptors, Interleukin-2/metabolism
Surface Plasmon Resonance
Thermodynamics
Chemicals
Interleukin-2
Ligands
Receptors, Interleukin-2
Authors & Affiliations
12 authors, click to expand affiliations / ORCID
Arkin Michelle R
Department of Biology, Sunesis Pharmaceuticals, South San Francisco, CA 94080-1913, USA. mra@sunesis.com
Randal Mike
DeLano Warren L
Hyde Jennifer
Luong Tinh N
Oslob Johan D
Raphael Darren R
Taylor Lisa
Wang Jun
McDowell Robert S
Wells James A
Braisted Andrew C
References (25)
25 references, click to expand
-
Configurational effects in antibody-antigen interactions studied by microcalorimetry.
Proteins. 1995 Feb;21(2):83-90
PMID: 7539913
-
Localization in human interleukin 2 of the binding site to the alpha chain (p55) of the interleukin 2 receptor.
Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4636-40
PMID: 2052547
-
Protein-protein interfaces: mimics and inhibitors.
Curr Opin Chem Biol. 2001 Dec;5(6):654-9
PMID: 11738175
-
Definition and spatial location of mouse interleukin-2 residues that interact with its heterotrimeric receptor.
EMBO J. 1993 Dec 15;12(13):5113-9
PMID: 8262055
-
Proteinminus signProtein Interactions: Interface Structure, Binding Thermodynamics, and Mutational Analysis.
Chem Rev. 1997 Aug 5;97(5):1233-1250
PMID: 11851449
-
Mutant proteins of human interleukin 2. Renaturation yield, proliferative activity and receptor binding.
Eur J Biochem. 1989 Mar 15;180(2):295-300
PMID: 2647490
-
Convergent solutions to binding at a protein-protein interface.
Science. 2000 Feb 18;287(5456):1279-83
PMID: 10678837
-
Response.
Science. 1992 Jul 17;257(5068):412-3
PMID: 17832837
-
Structure and expression of a cloned cDNA for human interleukin-2.
Nature. 1983 Mar 24-30;302(5906):305-10
PMID: 6403867
-
Interleukin-2 receptor beta chain: molecular cloning and functional expression of the human cDNA.
Cold Spring Harb Symp Quant Biol. 1989;54 Pt 2:689-94
PMID: 2640623
-
Structure and specific binding of trypsin: comparison of inhibited derivatives and a model for substrate binding.
J Mol Biol. 1974 Feb 25;83(2):209-30
PMID: 4821871
-
Improved methods for building protein models in electron density maps and the location of errors in these models.
Acta Crystallogr A. 1991 Mar 1;47 ( Pt 2):110-9
PMID: 2025413
-
Rapid and efficient site-specific mutagenesis without phenotypic selection.
Proc Natl Acad Sci U S A. 1985 Jan;82(2):488-92
PMID: 3881765
-
The atomic structure of protein-protein recognition sites.
J Mol Biol. 1999 Feb 5;285(5):2177-98
PMID: 9925793
-
Site-directed ligand discovery.
Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9367-72
PMID: 10944209
-
Molecular cloning of human interleukin 2 cDNA and its expression in E. coli.
Nucleic Acids Res. 1983 Jul 11;11(13):4307-23
PMID: 6306584
-
Structural plasticity in a remodeled protein-protein interface.
Science. 1997 Nov 7;278(5340):1125-8
PMID: 9353194
-
Designing non-peptide peptidomimetics in the 21st century: inhibitors targeting conformational ensembles.
J Med Chem. 2002 Jan 31;45(3):541-58
PMID: 11806706
-
Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor.
J Mol Biol. 2002 Feb 22;316(3):769-87
PMID: 11866530
-
Multiple diverse ligands binding at a single protein site: a matter of pre-existing populations.
Protein Sci. 2002 Feb;11(2):184-97
PMID: 11790828
-
Functional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 2.8 A.
Science. 1996 Jul 26;273(5274):464-71
PMID: 8662530
-
The finer things in X-ray diffraction data collection.
Acta Crystallogr D Biol Crystallogr. 1999 Oct;55(Pt 10):1718-25
PMID: 10531521
-
Molecular cloning of cDNA encoding human interleukin-2 receptor.
Nature. 1984 Oct 18-24;311(5987):631-5
PMID: 6090949
-
A thermodynamic characterization of the binding of thrombin inhibitors to human thrombin, combining biosensor technology, stopped-flow spectrophotometry, and microcalorimetry.
Anal Biochem. 2002 Jan 15;300(2):152-62
PMID: 11779106
-
The solution structure of the F42A mutant of human interleukin 2.
J Mol Biol. 1995 Apr 14;247(5):979-94
PMID: 7723044